Bicocca Open Archive

Logo unimib boa
AROLDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.638
AS - Asia 2.366
EU - Europa 1.717
SA - Sud America 368
AF - Africa 55
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.555
SG - Singapore 721
VN - Vietnam 674
IT - Italia 655
CN - Cina 466
BR - Brasile 294
RU - Federazione Russa 261
HK - Hong Kong 223
DE - Germania 219
IE - Irlanda 133
SE - Svezia 129
GB - Regno Unito 75
KR - Corea 54
IN - India 47
FI - Finlandia 44
CA - Canada 40
FR - Francia 35
ID - Indonesia 35
PL - Polonia 33
NL - Olanda 31
ZA - Sudafrica 30
AR - Argentina 28
MX - Messico 28
JP - Giappone 23
BD - Bangladesh 22
ES - Italia 22
TR - Turchia 22
AT - Austria 19
IQ - Iraq 15
UA - Ucraina 14
CO - Colombia 11
EC - Ecuador 10
PK - Pakistan 10
VE - Venezuela 9
CZ - Repubblica Ceca 8
EG - Egitto 8
LT - Lituania 8
PT - Portogallo 8
ET - Etiopia 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
IL - Israele 5
NO - Norvegia 5
PY - Paraguay 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CH - Svizzera 4
CL - Cile 4
KE - Kenya 4
MA - Marocco 4
BG - Bulgaria 3
KG - Kirghizistan 3
NP - Nepal 3
PE - Perù 3
UY - Uruguay 3
AM - Armenia 2
AU - Australia 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
FJ - Figi 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.148
Salva come PNG Salva come JPEG
Città #
Ann Arbor 545
Singapore 405
Ashburn 344
Milan 232
Hong Kong 215
Ho Chi Minh City 210
Dallas 202
Hanoi 185
Dublin 133
Frankfurt am Main 124
New York 124
Hefei 118
Los Angeles 111
Chandler 86
Beijing 83
Fairfield 70
Wilmington 68
Santa Clara 66
Woodbridge 62
Seoul 52
Houston 45
Seattle 36
Shanghai 32
São Paulo 31
Munich 30
Buffalo 29
Jakarta 29
Kent 26
Rome 26
Warsaw 25
Chicago 24
Haiphong 24
Princeton 24
Johannesburg 23
Tokyo 22
Cambridge 20
Lissone 19
Monza 19
Poplar 19
The Dalles 19
Moscow 18
Guangzhou 17
Turku 17
Nuremberg 16
Orem 16
Thái Nguyên 16
Ha Long 14
Helsinki 14
Romola 14
Sesto San Giovanni 14
Stockholm 14
Atlanta 13
Biên Hòa 13
Chennai 13
Desio 13
London 13
Montreal 13
Toronto 13
Turin 13
Denver 12
Hải Dương 12
Lawrence 12
Altamura 11
Lappeenranta 11
Ninh Bình 11
Quận Bình Thạnh 11
Amsterdam 10
Bologna 10
Brooklyn 10
Da Nang 10
Mexico City 10
Phoenix 10
Rio de Janeiro 10
Salt Lake City 10
Baghdad 9
Bắc Ninh 9
Can Tho 9
Querétaro 9
Bắc Giang 8
Como 8
Curitiba 8
Dong Ket 8
Jacksonville 8
Quận Một 8
Quận Phú Nhuận 8
San Diego 8
Tianjin 8
Ankara 7
Belo Horizonte 7
Dearborn 7
Dhaka 7
Garbsen 7
Manaus 7
Seregno 7
Vũng Tàu 7
Boardman 6
Bogotá 6
Carate Brianza 6
Council Bluffs 6
Düsseldorf 6
Totale 4.585
Salva come PNG Salva come JPEG
Nome #
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 377
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 369
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 313
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 309
Chronic myeloid leukemia: Second-line drugs of choice 306
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 302
Idiopathic erythrocytosis: a germline disease? 275
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 269
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 268
Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers 262
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 236
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 228
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 227
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 216
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 205
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 200
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 196
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 190
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 189
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 185
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 182
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 179
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 176
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 170
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 169
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 166
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 162
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 159
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 148
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 147
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 130
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 109
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 89
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 72
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 65
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 31
Totale 7.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.174
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021428 0 0 0 0 0 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/20251.883 56 141 88 76 119 88 113 69 170 323 213 427
2025/20263.184 887 456 456 708 495 182 0 0 0 0 0 0
Totale 7.276